Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Adhera Therapeutics, Inc. (ATRX)

Other OTC - Other OTC Delayed Price. Currency in USD
0.7500+0.1100 (+17.19%)
At close: 11:43AM EST
Advertisement

Adhera Therapeutics, Inc.

8000 Innovation Parkway
Baton Rouge, LA 70820
United States
919 518 3748
https://adherathera.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Zahed Subhan B.S., BS, L.L.B., LLB (Law), M.B.A., M.S., MBA, MSCEO, Chief Scientific Officer & Chairman8.33kN/A1958
Mr. Andrew Albert Kucharchuk M.B.A.COO, CFO, Corp. Devel. and Investor Relations & Vice Chairman186kN/A1981
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Corporate Governance

Adhera Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement